Prostate cancer is the second leading cause of cancer death in men in the U.S., with an expected 288,000 cases and 34,700 deaths expected in 2023, per the American Cancer Society. As artificial ...
TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company developing AI-powered, incision-free ...
MINNEAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of ...
Francis Medical has just received a fresh infusion of cash on its journey to treat prostate cancer. This week, the Maple Grove-based company announced that it has closed on an $80 million Series C ...
The U.S. Food and Drug Administration is expediting the review process for Francis Medical’s prostate cancer therapy technology, a process that happens when a new treatment could be more effective ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback